Join the Atopic Dermatitis group to help and get support from people like you.
Atopic Dermatitis News
Related terms: Atopic Eczema, Dermatitis, Atopic, Discoid Eczema, Infantile Eczema
Early Dog Exposure May Modify Genetic Effect on Atopic Eczema Risk
MONDAY, June 9, 2025 – Early-life dog exposure may modify the genetic effect of the single nucleotide variant rs10214237 on atopic eczema (AE) via IL7R, according to a study published online June 4...
Fido Might Protect Your Baby Against Eczema
THURSDAY, June 5, 2025 — Having a family dog might decrease a baby’s risk of developing eczema later in childhood, a new evidence review says. Specifically, exposure to canines appears to influence a ...
AAP Updates Guidelines for Pediatric Atopic Dermatitis Management
MONDAY, May 19, 2025 – In a clinical report published online May 19 in Pediatrics, the American Academy of Pediatrics presents updated guidance for the treatment of children with atopic dermatitis ...
Global Burden of Atopic Dermatitis in Older Adults Is Considerable
WEDNESDAY, May 7, 2025 – The global burden of atopic dermatitis (AD) in older adults is considerable and is expected to continue increasing to 2050, according to a study published online April 1 in...
Early-Onset Pediatric Atopic Dermatitis Tied to Higher Risk for Uveitis
WEDNESDAY, April 23, 2025 – Children with early-onset atopic dermatitis (AD) have an elevated risk for pediatric uveitis, according to a study published online April 3 in JAMA Ophthalmology. Yung-Yu ...
Roflumilast Cream 0.05 Percent Safe, Effective in Young Children With Eczema
FRIDAY, March 14, 2025 – Once-daily roflumilast cream 0.05 percent is safe and effective for atopic dermatitis (AD) in patients ages 2 to 5 years, according to a study published online Feb. 20 in P...
AAD: Maintenance of Low Eczema Activity Seen After About 80 Days Off Tapinarof
FRIDAY, March 14, 2025 – Patients with atopic dermatitis (AD) who achieve completely clear skin with tapinarof (Vtama) cream maintain low disease activity after about 80 days off treatment,...
Early Childhood Stressful Life Events Linked to Increased Eczema Activity
WEDNESDAY, Feb. 5, 2025 – For children with atopic dermatitis (AD), early childhood stressful life events are associated with an increased risk for disease activity, according to a study published...
Study IDs Signs of Topical Steroid Withdrawal in Atopic Dermatitis
WEDNESDAY, Jan. 22, 2025 – Self-reported manifestations of topical steroid withdrawal (TSW) in atopic dermatitis (AD) include erythema, desquamation, dryness, and oozing affecting the face, neck,...
FDA Expands Approval of Vtama to Include Atopic Dermatitis
THURSDAY, Dec. 19, 2024 – The U.S. Food and Drug Administration has approved Vtama (tapinarof) 1 percent cream for an additional indication – the topical treatment of atopic dermatitis in adult and...
FDA Approves Nemluvio for Moderate-to-Severe Atopic Dermatitis
WEDNESDAY, Dec. 18, 2024 – The U.S. Food and Drug Administration has approved Nemluvio (nemolizumab) for the treatment of moderate-to-severe atopic dermatitis in patients aged 12 years and older. ...
FDA Approves Vtama (tapinarof) Cream for the Treatment of Atopic Dermatitis in Adults and Children 2 Years of Age and Older
JERSEY CITY, N.J.--(BUSINESS WIRE) December 16, 2024 – Organon (NYSE: OGN), a global healthcare company with a mission to improve the health of women throughout their lives, today announced that...
Galderma Receives U.S. FDA Approval for Nemluvio (nemolizumab) for Patients with Moderate-to-Severe Atopic Dermatitis
Zug, Switzerland – December 13, 2024 – Galderma today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Nemluvio (nemolizumab) for the treatment of patients 12 ye...
Dupilumab Efficacious for Atopic Dermatitis in Young Children
WEDNESDAY, Dec. 11, 2024 – Dupilumab treatment improves signs and symptoms of atopic dermatitis (AD) in young children, according to a study published in the December issue of Advances in Therapy. ...
FDA Medwatch Alert: Do Not Purchase or Use Skin-Cap Aerosol Spray Products Because They May Be Harmful to Your Health
October 30, 2024 – FDA is warning consumers to not purchase or use Skin-Cap aerosol spray products because they may contain undisclosed steroids. This product, sold by Chemigroup France, formerly...
Further information
Related condition support groups
Related drug support groups
prednisone, methylprednisolone, clobetasol, Dupixent, fluocinonide, dexamethasone, desonide, halobetasol, dupilumab